CurrentCardio coverage · page 2 of 3

The Lancet

Briefs 41–80 of 84 CurrentCardio has covered from this journal, newest publication first

Latest from The Lancet

All coverage, newest first

Lancet31 Mar 2025
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
Randomised controlled trialPrevention & lipids
Lancet30 Mar 2025
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trial
Randomised controlled trialCoronary & ACS
Lancet30 Mar 2025
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Randomised controlled trial
Lancet30 Mar 2025
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial
Randomised controlled trialCoronary & ACS
Lancet30 Mar 2025
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial
Randomised controlled trialCoronary & ACS
Lancet29 Mar 2025
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
Randomised controlled trialCardiometabolic & kidney
Lancet1 Mar 2025
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial
Randomised controlled trialPulmonary vascular & VTE
Lancet26 Feb 2025
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial
Randomised controlled trialArrhythmias & EP
Lancet4 Dec 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial
Randomised controlled trialValvular & structural
Lancet30 Oct 2024
Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial
Randomised controlled trialCoronary & ACS
Lancet28 Oct 2024
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial
Randomised controlled trialCoronary & ACS
Lancet23 Oct 2024
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial
Randomised controlled trialArrhythmias & EP
Lancet19 Oct 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial
Randomised controlled trialHypertension
Lancet2 Sep 2024
Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial
Randomised controlled trialCoronary & ACS
Lancet2 Sep 2024
Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea
Randomised controlled trialCoronary & ACS
Lancet2 Sep 2024
Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up
Meta-analysisAcute care & resuscitation
Lancet1 Sep 2024
Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis
Meta-analysisHeart failure
Lancet31 Aug 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials
Meta-analysisCoronary & ACS
Lancet30 Aug 2024
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
Meta-analysisHeart failure
Lancet17 Aug 2024
Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial
Randomised controlled trialHeart failure
Lancet27 Jun 2024
Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial
Randomised controlled trialHypertension
Lancet7 Jun 2024
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial
Randomised controlled trialAortic & peripheral
Lancet22 May 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial
Randomised controlled trialValvular & structural
Lancet8 Apr 2024
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial
Randomised controlled trialCoronary & ACS
Lancet8 Apr 2024
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial
Randomised controlled trialCoronary & ACS
Lancet8 Apr 2024
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial
Randomised controlled trial
Lancet7 Apr 2024
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
Randomised controlled trial
Lancet21 Feb 2024
Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis
Meta-analysisCoronary & ACS
Lancet15 Feb 2024
Targeted prophylactic anticoagulation based on the TRiP(cast) score in patients with lower limb immobilisation: a multicentre, stepped wedge, randomised implementation trial
Randomised controlled trialPulmonary vascular & VTE
Lancet12 Dec 2023
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
Cross-sectional studyPrevention & lipids
Lancet14 Nov 2023
Treatment of severe symptomatic aortic valve stenosis using non-invasive ultrasound therapy: a cohort study
Cohort studyValvular & structural
Lancet25 Oct 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial
Randomised controlled trialCoronary & ACS
Lancet24 Oct 2023
Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis
Meta-analysisAortic & peripheral
Lancet31 Aug 2023
Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study
Cohort studyValvular & structural
Lancet27 Aug 2023
Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest (ARREST): a UK prospective, multicentre, parallel, randomised clinical trial
Randomised controlled trialAcute care & resuscitation
Lancet26 Aug 2023
Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials
Meta-analysisAcute care & resuscitation
Lancet25 Aug 2023
Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial
Randomised controlled trialArrhythmias & EP
Lancet24 Aug 2023
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
Randomised controlled trialHeart failure
Lancet15 Jun 2023
Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
Randomised controlled trialArrhythmias & EP
Lancet20 May 2023
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial
Randomised controlled trial

All 84 Briefs in ExploreShowing Briefs 41–80 of 84, newest first